Genomics

Dataset Information

0

DNA hypomethylating agents increase activation and cytolytic activity of CD8+ T-cells


ABSTRACT: DNA hypomethylating agents (HMAs) induce Type I/III interferon signaling through dsRNA-mediated viral mimicry in cancer cells. Yet, the direct effects of HMAs in immune cells remains less clear. Here, we demonstrate that HMA treatments can directly modulate the anti-tumor response and effector function of CD8+ T-cells. In vivo HMA treatment promotes CD8+ T-cell tumor infiltration and supresses tumor growth via CD8+ T-cell dependent activity. HMAs enhances primary human CD8+ T-cells activation markers, effector cytokine production, and anti-tumor cytolytic activity. Epigenomic and transcriptomic profiling shows that HMAs vastly regulate T-cell activation related transcriptional networks, culminating with over-activation of NFATc1 short-isoforms. Mechanistically, demethylation of an intragenic CpG Island immediately downstream to the 3'UTR of the short isoform was associated with anti-sense transcription and alternative polyadenylation of NFATc1 short-isoforms. High-dimensional single-cell mass cytometry (CyTOF) analyses reveal a selective effect of HMAs on a subset of human CD8+ T-cell subpopulations, resulting in an increase in both number and abundance of a granzymeBhigh, perforinhigh effector subpopulation. Overall, our findings support the use of HMAs as a therapeutic strategy to boost anti-tumor immune response.

ORGANISM(S): Homo sapiens

PROVIDER: GSE151917 | GEO | 2021/02/08

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2024-07-25 | PXD050539 | Pride
2024-07-24 | GSE261338 | GEO
2024-07-24 | GSE261337 | GEO
2023-06-16 | MSV000092193 | MassIVE
2022-06-20 | GSE188249 | GEO
2022-06-20 | GSE186825 | GEO
2023-04-24 | GSE175758 | GEO
2022-08-31 | GSE171053 | GEO
2016-07-01 | E-MTAB-4665 | biostudies-arrayexpress
| PRJNA1147731 | ENA